Bydd Cwmni Egino – enw’r cwmni datblygu – yn helpu i sicrhau’r buddiannau economaidd y gall adweithydd modiwlar bach a’r technolegau cysylltiedig eu cynnig, gan gynnwys adweithydd ymchwil feddygol i ddarparu cyflenwad diogel a chynaliadwy o radioisotopau meddygol ar gyfer Cymru, y DU ac Ewrop.
The development company - to be known as Cwmni Egino - will help exploit the economic benefits of small modular reactors and associated technologies on site, including the potential for a medical research reactor, to provide a secure and sustainable supply of medical radioisotopes for Wales, the UK and Europe.